Publications:30
Accepting New Patients
Treats Children & Adults
Accepting New Patients
Accepting New PatientsMichael Cameron, MD
Dermatology
No Patient Experience Ratings
Book an Appointment
About Me
Dr. Michael C. Cameron is the founder of Cameron Dermatology PLLC and an Assistant Clinical Professor in the Department of Dermatology at Mount Sinai in New York City. He is a board-certified dermatologist with expertise in drug development and inflammatory skin diseases with previous experience in the pharmaceutical industry, healthcare consulting, and academic medicine. He is a consultant for various biotech and pharmaceutical companies.
Dr. Cameron completed his residency training at Memorial Sloan Kettering Cancer Center and the University of Colorado. Prior to residency training, he received his undergraduate degree from Duke University and his medical degree from the University of South Florida.
Previously a medical director at Pfizer, Dr. Cameron prides himself on remaining up-to-date on the latest treatment options for his patients. He has expertise in the treatment of eczema, psoriasis, alopecia areata and other types of hair loss, vitiligo, acne, and skin cancer, as well as in performing various cosmetic treatments including botox, fillers, lasers, liposuction, RF microneedling, PRP, and chemical peels. He is co-author of more than 20 publications in peer-reviewed medical journals and 2 dermatology textbook chapters. He has also presented his research at various medical conferences.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Eczema, Skin Cancer
About Me
Dr. Michael C. Cameron is the founder of Cameron Dermatology PLLC and an Assistant Clinical Professor in the Department of Dermatology at Mount Sinai in New York City. He is a board-certified dermatologist with expertise in drug development and inflammatory skin diseases with previous experience in the pharmaceutical industry, healthcare consulting, and academic medicine. He is a consultant for various biotech and pharmaceutical companies.
Dr. Cameron completed his residency training at Memorial Sloan Kettering Cancer Center and the University of Colorado. Prior to residency training, he received his undergraduate degree from Duke University and his medical degree from the University of South Florida.
Previously a medical director at Pfizer, Dr. Cameron prides himself on remaining up-to-date on the latest treatment options for his patients. He has expertise in the treatment of eczema, psoriasis, alopecia areata and other types of hair loss, vitiligo, acne, and skin cancer, as well as in performing various cosmetic treatments including botox, fillers, lasers, liposuction, RF microneedling, PRP, and chemical peels. He is co-author of more than 20 publications in peer-reviewed medical journals and 2 dermatology textbook chapters. He has also presented his research at various medical conferences.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Eczema, Skin Cancer
Clinical Focus
- Acne
- Acne Scars
- Acne Vulgaris
- Actinic Keratosis
- Adolescent Dermatology
- Age Spots
- Aging Skin
- Alopecia Areata
- Anti-Aging Treatment
Show More
Education
MD, University of South Florida College of Medicine
BS, Duke University
Internship, Transitional Year
Memorial Sloan-Kettering Cancer Center
Residency, Dermatology
University of Colorado School of Medicine-Denver
Certifications
American Board of Dermatology
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel. Milaan Shah, Joshua Burshtein, Danny Zakria, Erin Boh, Michael Cameron, Brad Glick, Alexandra Golant, George Han, Sylvia Hsu, Benjamin Lockshin, Andrea Neimann, David Rosmarin, Mark Lebwohl. Journal of Drugs in Dermatology
- Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study. Nina Magnolo, Michael C. Cameron, Mona Shahriari, Bob Geng, Brian M. Calimlim, Henrique Teixeira, Xiaofei Hu, Yang Yang, Yingyi Liu, Shiyu Zhang, Cristina Sancho Sanchez, Katherine Altman, Richard G. Langley. Journal of Dermatological Treatment
- Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials. Seemal R. Desai, Linda Stein Gold, Michael C. Cameron, Alexandra Golant, G. Michael Lewitt, Matthew J. Bruno, George Martin, Philip M. Brown, David S. Rubenstein, Victoria Butners, Anna M. Tallman. Dermatology and Therapy
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Cameron during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Eli Lilly And Company
- Incyte Corporation
- AbbVie, Inc.
- Dermavant Inc
- Regeneron Pharmaceuticals, Inc.
- AbbVie Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Cameron during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Eli Lilly And Company
- Incyte Corporation
- AbbVie, Inc.
- Dermavant Inc
- Regeneron Pharmaceuticals, Inc.
- AbbVie Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.